Cash collections from intangible royalty assets
Royalty Pharma Cash collections from intangible royalty assets increased by 9574.4% to $3.77M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2031.6%, from $177.00K to $3.77M. Over 4 years (FY 2021 to FY 2025), Cash collections from intangible royalty assets shows a downward trend with a -73.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase suggests successful monetization or growth in the intangible portion of the royalty portfolio.
Detailed definition
Represents cash inflows specifically derived from intangible royalty assets. These assets represent legal rights to futu...
Peer comparison
Comparable to intangible asset amortization or royalty income from intellectual property portfolios.
operating_proceeds_from_cash_collections_from_royalties__b34edcHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $39.44M | $37.93M | $38.03M | $35.68M | $35.70M | $1.03M | $537.00K | $617.00K | $200.00K | $250.00K | $235.00K | $13.54M | $486.00K | $390.00K | $227.00K | $177.00K | $240.00K | $264.00K | $39.00K | $3.77M |
| QoQ Change | — | -3.8% | +0.2% | -6.2% | +0.0% | -97.1% | -47.8% | +14.9% | -67.6% | +25.0% | -6.0% | >999% | -96.4% | -19.8% | -41.8% | -22.0% | +35.6% | +10.0% | -85.2% | >999% |
| YoY Change | — | — | — | — | -9.5% | -97.3% | -98.6% | -98.3% | -99.4% | -75.7% | -56.2% | >999% | +143.0% | +56.0% | -3.4% | -98.7% | -50.6% | -32.3% | -82.8% | >999% |
Cash collections from intangible royalty assets at Other Companies
Frequently Asked Questions
- What is Royalty Pharma's cash collections from intangible royalty assets?
- Royalty Pharma (RPRX) reported cash collections from intangible royalty assets of $3.77M in Q1 2026.
- How has Royalty Pharma's cash collections from intangible royalty assets changed year-over-year?
- Royalty Pharma's cash collections from intangible royalty assets increased by 2031.6% year-over-year, from $177.00K to $3.77M.
- What is the long-term trend for Royalty Pharma's cash collections from intangible royalty assets?
- Over 4 years (2021 to 2025), Royalty Pharma's cash collections from intangible royalty assets has grown at a -73.7% compound annual growth rate (CAGR), from $151.16M to $720.00K.
- What does cash collections from intangible royalty assets mean?
- Cash received from intangible royalty assets.